Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EBIT Growth

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 6.3197.66-47.11-18.43-26.72

What is the latest EBIT Growth ratio of BLISS GVS PHARMA ?

The latest EBIT Growth ratio of BLISS GVS PHARMA is 6.31 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar20246.31
Mar202397.66
Mar2022-47.11
Mar2021-18.43
Mar2020-26.72

How is EBIT Growth of BLISS GVS PHARMA Trending?

Years EBIT Growth % Change
Mar2024 6.31
-93.54
Mar2023 97.66
Positive
Mar2022 -47.11
Negative
Mar2021 -18.43
Negative
Mar2020 -26.72 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EBIT Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,693.2 Cr 0.6% 26.7% 15.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,892.0 Cr 3.7% -3.2% 46.6% Stock Analytics
DIVIS LABORATORIES ₹166,129.0 Cr 5.1% 6.1% 64% Stock Analytics
CIPLA ₹121,231.0 Cr 0.6% -3.7% 26.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,431.0 Cr 1.9% -3.4% 5.8% Stock Analytics
ZYDUS LIFESCIENCES ₹97,639.9 Cr 2.3% -3.4% 54% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

0.6%

26.7%

15.8%

SENSEX

0.9%

2%

21%


You may also like the below Video Courses